Moreover, few of them (UNC1999 and GSK343, an analogue of GSK126) have been tested against GBM in vitro and in vivo, proving the relevance of EZH2 as target to fight in this disorder [15, 16]. The gene discussed is EZH2; the disease is glioblastoma.